» Articles » PMID: 33505446

Necrotising Otitis Externa: A Single Centre Experience

Overview
Journal J Otol
Date 2021 Jan 28
PMID 33505446
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Necrotising otitis externa (NOE) is a rare infection of the ear canal with frequent bone erosion. This study's objective is to describe the different features of NOE as well as its management in an ear-nose-throat department. We also tried to identify the particularities of the fungal infection.

Patients And Methods: It is an observational cohort that included all the patients hospitalised for the management of NOE. The study was carried out in the ear-nose-throat Department of Mahdia University Hospital in Tunisia between January 2006 and december 2019.

Results: A total of 40 patients were included. The mean age was 65 ± 12.9 years and the sex ratio was 0.9. Ninety percent of the patients included were diabetics. The most common signs found were oedema of the external canal (97.5%) and auricular discharge (92.5%). The main pathogen isolated was (61.7%). Fungi were isolated in 9 cases (26.47%). Computed tomography was performed for 32 patients (80%). Bone erosion was seen in 26 cases (81.3%). The main complications were cerebral venous thrombosis, retropharyngeal abscess and cerebral empyema. Thirty one patients received only antibiotics, 2 received only antifungal treatment, and 7 received both antibiotics and antifungal treatment. All patients had a favorable outcome. Univariate analysis showed a higher median erythrocyte sedimentation rate was associated with fungal infections. No other differences were noted.

Conclusion: Our management protocol seems to be efficient since all patients had initial favorable outcome. A higher median erythrocyte sedimentation rate was associated with fungal infections.

Citing Articles

Biomarker Analysis in Upper Respiratory Tract Infections: Associations with Demographics and Clinical Outcomes.

Manole F, Manole A, Csep A, Davidescu L, Hozan C, Szilagy E Pediatr Rep. 2025; 17(1.

PMID: 39846516 PMC: 11755654. DOI: 10.3390/pediatric17010001.


Malignant Otitis Externa: A persistent challenge.

Khribi M, El Abed W, Gnaba K Tunis Med. 2024; 102(8):478-482.

PMID: 39129575 PMC: 11390007. DOI: 10.62438/tunismed.v102i8.4867.


The Association Between Malignant Otitis Externa and Diabetes Mellitus in Africa: A Systematic Review.

Azeez T, Adeagbo A Indian J Otolaryngol Head Neck Surg. 2023; 75(4):3277-3287.

PMID: 37974885 PMC: 10645783. DOI: 10.1007/s12070-023-03939-3.


Clinical Spectrum and Treatment Response of Malignant Otitis Externa Patients: A Rural Tertiary Care Centre Experience.

Ausekar S, Prasad K, Babu P, Joseph L, G I Cureus. 2023; 15(5):e39518.

PMID: 37366442 PMC: 10290759. DOI: 10.7759/cureus.39518.


Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.

Durojaiye O, Slucka A, Kritsotakis E Eur J Clin Microbiol Infect Dis. 2022; 41(6):941-949.

PMID: 35556187 DOI: 10.1007/s10096-022-04455-y.


References
1.
Courson A, Vikram H, Barrs D . What are the criteria for terminating treatment for necrotizing (malignant) otitis externa?. Laryngoscope. 2013; 124(2):361-2. DOI: 10.1002/lary.24093. View

2.
Bray C, Bell L, Liang H, Haykal R, Kaiksow F, Mazza J . Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ. 2017; 115(6):317-21. View

3.
Mardassi A, Turki S, Lahiani R, Mbarek H, Benzarti S, Gharsallah H . Is there a real benefit of hyperbaric oxygenotherapy in the treatment of necrotizing otitis externa?. Tunis Med. 2017; 94(12):863. View

4.
Omran A, El Garem H, Al Alem R . Recurrent malignant otitis externa: management and outcome. Eur Arch Otorhinolaryngol. 2011; 269(3):807-11. DOI: 10.1007/s00405-011-1736-2. View

5.
Stern Shavit S, Bernstine H, Sopov V, Nageris B, Hilly O . FDG-PET/CT for diagnosis and follow-up of necrotizing (malignant) external otitis. Laryngoscope. 2018; 129(4):961-966. DOI: 10.1002/lary.27526. View